Opinion
Video
Identifying Patients Eligible for RSV Vaccine
Experts from clinical and payer backgrounds discuss how patients eligible for the RSV vaccine can be identified.
Video Player is loading.
Video content above is prompted by the following questions:
- How have eligible patients for the RSV vaccine been identified in pharmacies and health systems? Have RSV vaccines become annual immunizations like flu vaccines?
- Have electronic health records been built to identify eligible patients and incorporate RSV vaccines immunization records? How has the identification of eligible patients been implemented into workflow?
- From a payer perspective, how have you ensured eligible patients are identified for immunization?
- From a payer perspective, how have you ensured eligible patients are identified for immunization?
Related Videos
Factoring Cost, Recommendations, and Evidence Into Formulary Decisions about Lp(a) Testing
Assessing the Quality of Recommendations and Making Clinical Decisions About Lp(a) Testing
Evidence Supporting 2024 Guidance for Lp(a) Testing
The Role of Management Guidelines in Formulary Decision-Making and Recent Lp(a) Recommendations
A Case Study of Elevated Lp(a) Levels and Increased ASCVD Risk
How the Genetic Nature of Lp(a) Levels Influences Screening
Building Better Collaboration: Reducing Care Delays in Managing mCRC
Best Practices for Overcoming mCRC Prior Authorization Barriers
Lp(a) Levels: A Continuous Relationship With ASCVD Levels and Consistent Throughout a Lifetime
Studying the Association Between Elevated Lp(a) Levels and Risk of Atherosclerotic Disease
Related Content
